88 results
10-Q
2024 Q3
EX-10.1
INM
InMed Pharmaceuticals Inc
Quarterly report
13 May 24
6:27pm
8-K
EX-10.1
INM
InMed Pharmaceuticals Inc
9 Feb 24
InMed Pharmaceuticals Strengthens Executive Leadership Team with Appointment of Ms. Netta Jagpal as Chief Financial Officer
12:34pm
8-K
EX-10.2
INM
InMed Pharmaceuticals Inc
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
8-K
EX-10.3
INM
InMed Pharmaceuticals Inc
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
8-K
EX-10.1
INM
InMed Pharmaceuticals Inc
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
8-K
EX-10.2
3wmhp3t
13 Dec 22
InMed Announces Appointment of Interim Chief Financial Officer and Change of Auditor
3:47pm
8-K
EX-10.1
xjlu6q8o2u
13 Dec 22
InMed Announces Appointment of Interim Chief Financial Officer and Change of Auditor
3:47pm
8-K
EX-10.1
nx8f57gtqbb rmtz33ax
21 Nov 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
7:02pm
8-K
EX-10.2
7ll1yfer5xxzs
21 Nov 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
7:02pm
8-K
EX-10.1
w31liii
13 Sep 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
9:59pm
8-K
EX-10.2
nwlvck2p
13 Sep 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
9:59pm
8-K
EX-10.1
2v1o5ba 3m5y8yqhl
19 Jul 22
InMed Announces Appointment of Chief Operating Officer
7:43pm
8-K
EX-10.1
rq1pu0q7xkrwj5
15 Jul 22
Departure of Directors or Certain Officers
8:28pm
8-K
EX-10.2
xfh9n45abjaz1tfqywjt
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
8-K
EX-10.3
iocp5cbypenn0wp
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
8-K
EX-10.1
p71mswymnalmcwasn3g
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
8-K
EX-10.1
m5fun4 726ea5e
7 Apr 22
Entry into a Material Definitive Agreement
4:47pm